Sort
30,917 grants matching “tumor microenvironment”
PROSTATE CANCER-BONE INTERACTION--SECRETION OF EGFR
$251,115Children'S Hospital Boston · R01 · FY2002 · CA
Spatially Resolved, Multi-Omics Analyses of Immune Infiltrates in GBM Microenvironment
$251,087Jennifer Mary Garbarino · Atlasxomics Inc. · R43 · FY2022 · CA
Biologic Therapy for B-cell non-Hodgkin's Lymphoma
$250,979Stephen M Ansell · Mayo Clinic Rochester · R01 · FY2011 · CA
Combination of CB101 and radiation therapy in head and neck squamous cell carcinoma
$250,876Louis I Schure · Curebiotech, Inc. · R41 · FY2022 · CA
Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology
$250,795David Liu · Dana-Farber Cancer Inst · K08 · FY2020 · CA
Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology
$250,795David Liu · Dana-Farber Cancer Inst · K08 · FY2021 · CA
Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology
$250,795David Liu · Dana-Farber Cancer Inst · K08 · FY2022 · CA
Genetic Regulation of Angiogenesis in Colonic Polyps
$250,774Daniel C Chung · Massachusetts General Hospital · R01 · FY2010 · CA
Genetic Regulation of Angiogenesis in Colonic Polyps
$250,774Daniel C Chung · Massachusetts General Hospital · R01 · FY2009 · CA
P-3: Targeting Tumor Microenvironment in NSCLC
$250,764Jonathan M Kurie · Ut Southwestern Medical Center · P50 · FY2012 · CA
Core Support for Cancer Center
$250,747Edward Chu · Albert Einstein College Of Medicine · P30 · FY2021 · CA
Metabolic Oxidative Stress and TRAIL Cytotoxicity
$250,632Yong J Lee · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · CA
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease
$250,630Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Treg-depleting immunotherapy
$250,548Peter David Suzdak · Sonoval Llc · R44 · FY2020 · CA
Circulating Antibodies to Oral Microbiota and Colon Cancer Risk
$250,540Dominique S Michaud · Tufts University Boston · R21 · FY2019 · CA
Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer
$250,509Jason B Fleming · University Of Tx Md Anderson Can Ctr · U54 · FY2019 · CA
Combining Anti-Angiogenesis Strategies and Radiotherapy
$250,486Dietmar W Siemann · University Of Florida · R01 · FY2009 · CA
Combining Anti-Angiogenesis Strategies and Radiotherapy
$250,486Dietmar W Siemann · University Of Florida · R01 · FY2010 · CA
Combining Anti-Angiogenesis Strategies and Radiotherapy
$250,486Dietmar W Siemann · University Of Florida · R01 · FY2008 · CA
Imaging Core
$250,483Karen H Martin · West Virginia University · P20 · FY2024 · GM
FUNCTIONAL DISSECTION OF THE K27M HISTONE MUTATION IN GLIOMAGENESIS
$250,471Oren Josh Becher · Lurie Children'S Hospital Of Chicago · R01 · FY2019 · CA
4:LYMPHOMA SUPPRESSION:DNA BREAK REPAIR IN STEM CELLS AND THEIR MICROENVIRONMENT
$250,424Kevin D Mills · Mainehealth · P20 · FY2010 · RR
Core Support for Cancer Center
$250,373Edward Chu · Albert Einstein College Of Medicine · P30 · FY2020 · CA
Project 4-Monika Rak
$250,347Monika Rak · Lsu Health Sciences Center · P20 · FY2024 · GM
Project 4-Monika Rak
$250,347Monika Rak · Lsu Health Sciences Center · P20 · FY2022 · GM